The use of unregulated peptides has surged in US wellness circles, with enthusiasts injecting these molecules for supposed health benefits. However, according to Live Science, this trend rests on limited clinical evidence despite widespread adoption.
Peptides, short chains of amino acids, are marketed for everything from muscle growth to anti-aging, but most are sold outside FDA oversight. This gray-market status means purity, dosing, and side effects remain poorly understood by consumers.
No specific data on usage rates or adverse events were provided in the source. The article highlights that many peptide vendors operate without regulatory scrutiny, making it difficult to verify product claims or safety profiles.
Public health experts worry that the lack of regulation could lead to contamination, misuse, or delayed treatment of underlying conditions. Patients may be drawn to peptides by anecdotal reports rather than rigorous studies.
Proponents argue that peptides offer a novel approach to wellness and that some compounds show promise in early research. However, they caution that individual results vary and more controlled trials are needed.